Cargando…
Commentary: Constipation caused by anti-calcitonin gene-related peptide migraine therapeutics explained by antagonism of calcitonin gene-related peptide’s motor-stimulating and prosecretory function in the intestine
Calcitonin gene-related peptide (CGRP) pathway-targeted treatments have been shown to be efficacious in the prevention of episodic and chronic migraine. Currently approved therapies include monoclonal antibodies (mAbs) that target CGRP (eptinezumab, fremanezumab, and galcanezumab) and the CGRP recep...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9747098/ https://www.ncbi.nlm.nih.gov/pubmed/36523559 http://dx.doi.org/10.3389/fphys.2022.1067274 |
_version_ | 1784849515799379968 |
---|---|
author | Mackenzie, Kimberly D. Ortega, Mario Kessler, Yoel Campos, Verena Ramirez Krasenbaum, Lynda J. Carr, Karen Ning, Xiaoping Stratton, Jennifer |
author_facet | Mackenzie, Kimberly D. Ortega, Mario Kessler, Yoel Campos, Verena Ramirez Krasenbaum, Lynda J. Carr, Karen Ning, Xiaoping Stratton, Jennifer |
author_sort | Mackenzie, Kimberly D. |
collection | PubMed |
description | Calcitonin gene-related peptide (CGRP) pathway-targeted treatments have been shown to be efficacious in the prevention of episodic and chronic migraine. Currently approved therapies include monoclonal antibodies (mAbs) that target CGRP (eptinezumab, fremanezumab, and galcanezumab) and the CGRP receptor (erenumab), and small molecule CGRP receptor antagonists (atogepant and rimegepant). While CGRP pathway–targeted treatments are generally well-tolerated, in a review article by Holzer and Holzer-Petsche published in the January 2022 issue of Frontiers in Physiology the authors discussed the role of the CGRP pathway in gastrointestinal physiology, with a specific focus on constipation associated with the use of CGRP pathway–targeted treatments. The authors state that real-world surveys have shown constipation to be a “major adverse event” reported in “more than 50% of patients treated with erenumab, fremanezumab or galcanezumab.” As described in the current commentary, the limited data from the cited references in the review article by Holzer and Holzer-Petsche do not support that statement. |
format | Online Article Text |
id | pubmed-9747098 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-97470982022-12-14 Commentary: Constipation caused by anti-calcitonin gene-related peptide migraine therapeutics explained by antagonism of calcitonin gene-related peptide’s motor-stimulating and prosecretory function in the intestine Mackenzie, Kimberly D. Ortega, Mario Kessler, Yoel Campos, Verena Ramirez Krasenbaum, Lynda J. Carr, Karen Ning, Xiaoping Stratton, Jennifer Front Physiol Physiology Calcitonin gene-related peptide (CGRP) pathway-targeted treatments have been shown to be efficacious in the prevention of episodic and chronic migraine. Currently approved therapies include monoclonal antibodies (mAbs) that target CGRP (eptinezumab, fremanezumab, and galcanezumab) and the CGRP receptor (erenumab), and small molecule CGRP receptor antagonists (atogepant and rimegepant). While CGRP pathway–targeted treatments are generally well-tolerated, in a review article by Holzer and Holzer-Petsche published in the January 2022 issue of Frontiers in Physiology the authors discussed the role of the CGRP pathway in gastrointestinal physiology, with a specific focus on constipation associated with the use of CGRP pathway–targeted treatments. The authors state that real-world surveys have shown constipation to be a “major adverse event” reported in “more than 50% of patients treated with erenumab, fremanezumab or galcanezumab.” As described in the current commentary, the limited data from the cited references in the review article by Holzer and Holzer-Petsche do not support that statement. Frontiers Media S.A. 2022-11-29 /pmc/articles/PMC9747098/ /pubmed/36523559 http://dx.doi.org/10.3389/fphys.2022.1067274 Text en Copyright © 2022 Mackenzie, Ortega, Kessler, Campos, Krasenbaum, Carr, Ning and Stratton. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Physiology Mackenzie, Kimberly D. Ortega, Mario Kessler, Yoel Campos, Verena Ramirez Krasenbaum, Lynda J. Carr, Karen Ning, Xiaoping Stratton, Jennifer Commentary: Constipation caused by anti-calcitonin gene-related peptide migraine therapeutics explained by antagonism of calcitonin gene-related peptide’s motor-stimulating and prosecretory function in the intestine |
title | Commentary: Constipation caused by anti-calcitonin gene-related peptide migraine therapeutics explained by antagonism of calcitonin gene-related peptide’s motor-stimulating and prosecretory function in the intestine |
title_full | Commentary: Constipation caused by anti-calcitonin gene-related peptide migraine therapeutics explained by antagonism of calcitonin gene-related peptide’s motor-stimulating and prosecretory function in the intestine |
title_fullStr | Commentary: Constipation caused by anti-calcitonin gene-related peptide migraine therapeutics explained by antagonism of calcitonin gene-related peptide’s motor-stimulating and prosecretory function in the intestine |
title_full_unstemmed | Commentary: Constipation caused by anti-calcitonin gene-related peptide migraine therapeutics explained by antagonism of calcitonin gene-related peptide’s motor-stimulating and prosecretory function in the intestine |
title_short | Commentary: Constipation caused by anti-calcitonin gene-related peptide migraine therapeutics explained by antagonism of calcitonin gene-related peptide’s motor-stimulating and prosecretory function in the intestine |
title_sort | commentary: constipation caused by anti-calcitonin gene-related peptide migraine therapeutics explained by antagonism of calcitonin gene-related peptide’s motor-stimulating and prosecretory function in the intestine |
topic | Physiology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9747098/ https://www.ncbi.nlm.nih.gov/pubmed/36523559 http://dx.doi.org/10.3389/fphys.2022.1067274 |
work_keys_str_mv | AT mackenziekimberlyd commentaryconstipationcausedbyanticalcitoningenerelatedpeptidemigrainetherapeuticsexplainedbyantagonismofcalcitoningenerelatedpeptidesmotorstimulatingandprosecretoryfunctionintheintestine AT ortegamario commentaryconstipationcausedbyanticalcitoningenerelatedpeptidemigrainetherapeuticsexplainedbyantagonismofcalcitoningenerelatedpeptidesmotorstimulatingandprosecretoryfunctionintheintestine AT kessleryoel commentaryconstipationcausedbyanticalcitoningenerelatedpeptidemigrainetherapeuticsexplainedbyantagonismofcalcitoningenerelatedpeptidesmotorstimulatingandprosecretoryfunctionintheintestine AT camposverenaramirez commentaryconstipationcausedbyanticalcitoningenerelatedpeptidemigrainetherapeuticsexplainedbyantagonismofcalcitoningenerelatedpeptidesmotorstimulatingandprosecretoryfunctionintheintestine AT krasenbaumlyndaj commentaryconstipationcausedbyanticalcitoningenerelatedpeptidemigrainetherapeuticsexplainedbyantagonismofcalcitoningenerelatedpeptidesmotorstimulatingandprosecretoryfunctionintheintestine AT carrkaren commentaryconstipationcausedbyanticalcitoningenerelatedpeptidemigrainetherapeuticsexplainedbyantagonismofcalcitoningenerelatedpeptidesmotorstimulatingandprosecretoryfunctionintheintestine AT ningxiaoping commentaryconstipationcausedbyanticalcitoningenerelatedpeptidemigrainetherapeuticsexplainedbyantagonismofcalcitoningenerelatedpeptidesmotorstimulatingandprosecretoryfunctionintheintestine AT strattonjennifer commentaryconstipationcausedbyanticalcitoningenerelatedpeptidemigrainetherapeuticsexplainedbyantagonismofcalcitoningenerelatedpeptidesmotorstimulatingandprosecretoryfunctionintheintestine |